Interlude Menopause Review 2026: Legit — But It Treats Only Vaginal and Urinary Symptoms
Before you choose Interlude
Interlude is a focused vaginal and urinary care route, not a comprehensive menopause program. Use the free path tool to separate local symptoms, systemic symptoms, insurance, pharmacy pricing, and in-person red flags.
This Interlude menopause review found a real, narrow-focus telehealth service for vaginal dryness, painful sex, urinary urgency, and recurrent UTI prevention—not systemic menopause care. The FDA-approved generic cream is $39 for the first tube plus a $45 consult, or about $84 to start. Refills are automatic, insurance is not accepted, and compounded options sit beside FDA-approved products.[1][2]
Interlude can be a very good door when the problem is access to vaginal estrogen. It is the wrong door when the problem is hot flashes, night sweats, sleep disruption, mood changes, bone-health planning, or a whole-menopause treatment plan.
We're not an Interlude affiliate. Interlude runs an affiliate program; we're not in it. Every Interlude link on this page is unpaid. We reviewed its current product pages, contracts, refund policy, pharmacy disclosures, medical copy, and eight places where its own pages still do not agree.
Best for you if
- Your main symptoms are vaginal or urinary: dryness, painful sex, burning, irritation, urgency, frequency, leaking, or UTIs that keep coming back.
- You are paying cash, between insurance plans, facing a high deductible, or cannot get a timely gynecology appointment.
- You want a focused online prescription process without scheduling a routine video visit.
- You want an FDA-approved generic vaginal estradiol option and will check the exact product before paying.
- You understand that recurring shipments start automatically and are willing to set or postpone the refill interval.
Not for you if
- Hot flashes, night sweats, sleep disruption, mood changes, or other systemic symptoms are the reason you came.
- You want a comprehensive menopause assessment or systemic hormone therapy.
- You want insurance billed.
- You already have a prescription and can fill it affordably at a local pharmacy.
- You want a vaginal ring; Interlude does not currently sell one.
- You want a clinician to review your history before your card is charged.
- You have bleeding after menopause, a new vulvar or vaginal lesion, significant pelvic pain, fever, flank pain, or another symptom that needs an examination or urgent diagnostic workup.
Interlude at a glance
| Decision fact | What we verified in August 2026 |
|---|---|
| Core scope | Vaginal and urinary symptoms, plus separate online visits for acute UTI, BV, and yeast treatment |
| Systemic HRT | Not offered |
| Lowest current product price | $39 first shipment for generic estradiol cream or Hyaluronic+ cream |
| Online consult | $45 one-time fee for routine prescription products |
| First generic-cream checkout | About $84 before tax or optional expedited shipping |
| Insurance | Not accepted |
| HSA/FSA | Interlude says cards are accepted; plan eligibility still controls reimbursement |
| FDA-approved options | Generic estradiol vaginal cream 0.01% and generic 10 mcg estradiol vaginal inserts |
| Compounded options | Soothing Estradiol Cream 0.003%, DHEA Vaginal Cream 2%, and Hyaluronic+ Topical Cream |
| Routine labs or physical exam | Not listed in Interlude's published routine workflow |
| Automatic refills | Yes; postpone a shipment or cancel all shipments |
| Cancellation deadline | At least two business days before the next shipment under the terms |
| Published state claim | Marketing says all 50 states; telehealth consent says certain states only—confirm before paying |
| Biggest commercial risk | The pricing page promises a full refund if you do not qualify; the refund policy says the $45 consult is not refunded |
The damaging admission belongs here, before the value case:
Interlude's $39 headline is not the price of care. It is the first product shipment. The first generic-cream checkout is about $84 after the $45 consult, later tubes are $59, and the default two-month cadence produces an illustrative first-year total of $379. A local pharmacy can be cheaper if you already have a prescriber or useful coverage.[1][2]
That does not make Interlude a bad deal. It tells you what you are buying: prescription access, clinician messaging, fulfillment, reminders, and delivery. When access is the obstacle, those things have value. When access is already solved, Interlude may be an unnecessary middle layer.
The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
→ Find My HRT Path — see which door fits your symptoms About 90 seconds. No account. It will also tell you when the right next step is in-person care.
What does Interlude treat—and what does it not treat?
Interlude treats the vaginal, vulvar, and lower-urinary side of menopause. Its published routine products target genitourinary syndrome of menopause, or GSM; it does not sell systemic estrogen patches, gels, sprays, or pills for hot flashes and night sweats. Separate $55 online visits are available for an active UTI, bacterial vaginosis, or a yeast infection, with medication paid for at the local pharmacy.[3][4]
| Symptom or need | Does Interlude address it? | Practical meaning |
|---|---|---|
| Vaginal dryness | Yes | FDA-approved and compounded prescription options are offered |
| Painful sex related to GSM | Yes | Local treatment options are offered after clinician review |
| Vulvar or vaginal burning and irritation | Yes | The diagnosis still matters; persistent or visible skin changes need examination |
| Urinary urgency or frequency associated with GSM | Yes | Local vaginal therapy may help some urinary symptoms |
| Recurrent UTIs after menopause | Yes, as prevention in appropriate patients | Local low-dose vaginal estrogen is supported by current urology guidance for reducing future UTI risk when appropriate[19] |
| Active UTI | Separate $55 visit | The $55 covers the online visit and prescription; the antibiotic is paid for at a local pharmacy[4] |
| Bacterial vaginosis | Separate $55 visit | Medication cost is separate at the local pharmacy[4] |
| Yeast infection | Separate $55 visit | Interlude advertises a $55 visit and prescription; medication cost is separate[4] |
| Hot flashes | No | Requires a systemic-symptom evaluation and, when appropriate, systemic treatment |
| Night sweats | No | Interlude's catalog does not include systemic menopause therapy |
| Sleep, mood, or brain-fog concerns | No comprehensive treatment path | These symptoms need a broader assessment rather than a vaginal-health-only service |
| Bone-loss prevention | No | Low-dose local vaginal estrogen is not the systemic regimen used for bone protection[20] |
| Vaginal ring | No | Interlude currently offers creams and 10 mcg inserts, not a ring |
| Bleeding after menopause | Not an online-product decision | Postmenopausal bleeding requires prompt clinical evaluation[21] |
GSM includes bothersome genital, sexual, and urinary symptoms related to reduced estrogen and other sex-steroid levels. The Menopause Society says it usually worsens over time without treatment, unlike hot flashes, which often improve with time.[18]
The language matters because “menopause care” can sound much broader than the service Interlude actually sells. Its current terms limit routine consultations to vaginal atrophy, GSM, and related conditions. Its current shop also sells separate acute-infection visits, which is one of the site's internal scope conflicts covered later.[4][5]
You may need local and systemic treatment—and that is not a failure
A woman taking systemic HRT can still have vaginal dryness, painful sex, urgency, or recurrent UTIs. The Menopause Society notes that some women using low-dose oral or transdermal hormone therapy still need vaginal estrogen for local symptom relief.[20]
So the decision is not always “Interlude or systemic HRT.” It can be:
- systemic care for hot flashes, night sweats, sleep, or broader menopause symptoms; and
- separate local treatment for GSM.
That combination requires an individualized clinician decision. Interlude's FAQ gives a broad “typically yes” answer to combining systemic HRT with vaginal estrogen, but your actual product, dose, history, and prescriber plan control the answer.[3]
If your symptoms are mostly systemic
Interlude is not the product you are looking for. Midi Health is a broader menopause-care route that says it operates in all 50 states and is in-network with many PPO plans, although coverage depends on the plan. Midi says Medicare beneficiaries may use self-pay care but cannot submit Medicare claims, and it says it cannot treat Medicaid or Medi-Cal patients even as self-pay.[27]
→ Check whether Midi Health takes your plan and treats your state For hot flashes, night sweats, sleep disruption, and broader menopause care. (Affiliate link.)
What is Interlude, and who actually provides the care?
Interlude is a cash-pay website operated under GML Health, Inc. Its own terms say GML Health is not the healthcare provider; an affiliated clinician reviews the health information through a separate telehealth platform, and outside pharmacies dispense the prescription. That structure is common in telehealth, but it creates three different relationships: platform, clinician, and pharmacy.[5][6]
Interlude's published terms list GML Health, Inc. and the mailing address 23823 Malibu Rd., Ste. 50-220, Malibu, CA 90265. Its telehealth consent repeatedly uses M&D Integrations, Inc. as the technology platform coordinating access to affiliated healthcare providers. Interlude's customer support number is (909) 378-6899, and its contact page lists support hours as Monday through Friday, 10 a.m. to 4 p.m. Pacific.[5][6][7]
The article does not treat a certification badge as proof of medical quality. The useful evidence is the actual operating structure:
- You choose a product and pay.
- You complete an online health assessment.
- A licensed clinician reviews the submission and may follow up by secure message, phone, or video.
- If a prescription is appropriate, an outside pharmacy dispenses and ships it.
- You can message the medical team through the secure account.
Interlude says its clinicians usually respond within hours; its FAQ says three to four hours, while the telehealth consent promises review within 24 hours and the contact page says medical messages receive a response within 24 hours.[3][6][7]
What the routine workflow does not include
Interlude's public routine GSM workflow does not list:
- laboratory testing;
- a pelvic examination;
- urine testing before every urinary treatment;
- an in-person vulvar or vaginal examination; or
- a scheduled comprehensive menopause visit.
That is why the service can be fast. It is also why symptoms that are new, severe, visible, recurrent despite treatment, or diagnostically unclear may need an in-person clinician instead. Interlude's own telehealth consent says remote care may lack information normally obtained through a physical examination and may produce a limited or provisional diagnosis.[6]
Provider-stated versus independently checked
| Claim | What Interlude publishes | What this review could independently establish |
|---|---|---|
| Platform identity | GML Health, Inc.; telehealth consent also uses M&D Integrations | Both names appear in current legal documents; the exact contracting chain should be confirmed in the patient's consent and receipt |
| Clinician review | Licensed MD or GYN; board-certified language appears on product pages | Prescription review is built into the published workflow; the individual clinician's name and state license must be checked after assignment |
| State availability | Marketing says all 50 states | Telehealth consent says only certain states and references a state list that did not surface; confirm before payment |
| Pharmacy partners | GoGoMeds, Honeybee Health, Blend, and Curexa | The four names are public; accreditation statements remain provider-stated unless checked directly with the accreditor |
| Compounded fulfillment | Curexa fulfills custom compounded products | Interlude says this directly on its contact page |
| FDA-approved product status | Generic 0.01% estradiol cream and 10 mcg inserts | Current FDA-recognized labels exist for these dosage forms; confirm the manufacturer and NDC on the dispensed package |
| Compounded product status | Soothing Estradiol 0.003%, DHEA 2%, Hyaluronic+ | Current pages label these as compounded; compounded drugs are not FDA-approved[14] |
| Consult price | $45 one-time routine online consult | Now published directly on current Interlude product pages |
This table is the reason the pharmacy label matters. A sales page can tell you the category. The label tells you the exact manufacturer, pharmacy, strength, and product you actually received.
Interlude menopause review: is it legit, or is it a scam?
Interlude is a functioning telehealth and pharmacy-fulfillment service, not a fake storefront. It publishes its operating entities, contact details, telehealth terms, pharmacy partners, prescription workflow, prices, refund policy, and account controls. The material questions are not whether it exists; they are whether its narrow scope fits you, which product you receive, what your first-year cost becomes, and which conflicting policy controls.
The strongest legitimacy evidence is practical:
- prescription products require clinician review;
- the clinician must be licensed where the patient is located;
- Interlude names four fulfillment partners;
- the current product pages distinguish FDA-approved generics from compounded formulas;
- the site publishes cancellation and refund terms; and
- a secure patient account is used for medical messages and shipment controls.[1][3][5][6][7]
The pharmacy name tells you more than the homepage badge
Interlude currently names four pharmacy partners:[7]
| Pharmacy | Interlude's stated role | Accreditation statement on Interlude's page |
|---|---|---|
| GoGoMeds | Medication fulfillment and delivery | Interlude says it retains NABP Digital Pharmacy Accreditation |
| Honeybee Health | Medication fulfillment and delivery | Interlude says it retains NABP accreditation |
| Blend | Medication fulfillment and delivery | Interlude says it retains NABP Healthcare Merchant Accreditation |
| Curexa Pharmacy | Custom compounded medication fulfillment | Interlude says it retains PCAB accreditation |
Do not stretch this table further than the source permits. Interlude specifically assigns custom compounded medications to Curexa. It does not publish a permanent product-by-product routing map showing that every FDA-approved generic will always come from one of the other three pharmacies. Partners and inventory can change.
When the package arrives, check:
- pharmacy name;
- drug name;
- strength;
- quantity;
- manufacturer;
- NDC;
- directions; and
- whether the label says it is compounded.
One thing to know before your card is charged
Payment comes before clinician review. Interlude's workflow says checkout happens first and the health assessment comes next.[3]
The financial consequence is not settled cleanly on its own site:
- the pricing page says your payment will be refunded if you do not qualify; but
- the refund policy says the medication fee is refunded and the medical-consult fee is not.[2][8]
That difference is $45 under current routine pricing.
Ask support one sentence before paying:
“If the clinician does not prescribe, will both the medication charge and the $45 consult fee be refunded?”
Get the answer in writing. This is not nervous overthinking. It is the exact question created by two live Interlude policies.
If assessment-before-payment is your line in the sand, a marketplace such as Sesame Care lets you choose a specific clinician and see the visit price before booking. Sesame is cash-pay and advertises visits starting at $34; medication costs are separate.[28]
→ Compare current gynecology and telehealth visit prices on Sesame Care Use this route when you want to choose the clinician or see the appointment price before the visit. (Affiliate link.)
→ See Interlude's current products and pricing Use this route when focused vaginal or urinary care is the right fit. Confirm the refund answer, product, and state before paying. (Unpaid link.)
How much does Interlude cost in 2026?
The FDA-approved generic estradiol cream costs $39 for the first tube and $59 for later tubes, plus a published $45 one-time consult, making the first checkout about $84 before tax or optional expedited shipping. At the default two-month cadence, six shipments produce a $379 illustrative first-year total. A three-month cadence produces $261; a four-month cadence produces $202.[1][2]
Those annual figures are The HRT Index calculations, not annual prices quoted by Interlude. They assume the current promotional and recurring prices stay unchanged, one $45 consult is charged, standard shipping remains free, and the selected interval continues for twelve months.
Current Interlude price and product ledger
| Product or visit | Regulatory category | Current published product price | Current published consult | First checkout before tax | Quantity or supply | Verification note |
|---|---|---|---|---|---|---|
| Estradiol vaginal cream 0.01% | FDA-approved generic | $39 first / $59 recurring | $45 | $84 | 42.5 g; Interlude says 2–3 months | Current product page |
| Estradiol vaginal inserts 10 mcg | FDA-approved generic | $109 first / $129 recurring | $45 | $154 | 18 inserts; Interlude calls it 2 months | At the page's published starter schedule, 18 inserts cover about 4 weeks; at twice-weekly maintenance, about 9 weeks |
| Soothing Estradiol Cream 0.003% | Compounded prescription | $49 first / $69 recurring | $45 | $94 | 30 g; Interlude says 2–3 months | Concentration is now published |
| DHEA Vaginal Cream 2% | Compounded prescription | $49 first / $69 recurring | $45 | $94 | 30 g; Interlude says 2 months | Each 0.25 g pump contains 5 mg DHEA |
| Hyaluronic+ Topical Cream | Compounded, nonhormonal prescription | $39 first / $59 recurring | $45 | $84 | 30 g; supply duration not stated on the current page | Confirm selected interval at checkout |
| Active UTI visit | Online visit and prescription | $55 visit | Included in $55 | $55 plus medication | Medication filled locally | Pharmacy drug cost is separate |
| BV visit | Online visit and prescription | $55 visit | Included in $55 | $55 plus medication | Medication filled locally | Pharmacy drug cost is separate |
| Yeast-infection visit | Online visit and prescription | $55 visit | Included in $55 | $55 plus medication | Medication filled locally | Pharmacy drug cost is separate |
Prices and catalog verified August 18, 2026.[1][4][9][10][11][12]
The insert supply needs its own arithmetic. Interlude publishes 18 inserts, calls the box a two-month supply, and describes a standard schedule of one insert daily for fourteen days followed by twice-weekly maintenance. A new starter following that published schedule would use fourteen inserts in the first two weeks and the remaining four over the next two weeks—about four weeks total. A patient already on twice-weekly maintenance would get about nine weeks. The actual prescription controls, but “two-month supply” is not universally true.[9]
What refill frequency does to the generic-cream cost
| Selected shipment interval | Shipments in 12 months | Calculation | Illustrative year-one total | Average per month |
|---|---|---|---|---|
| Every 2 months | 6 | $45 + $39 + five $59 refills | $379 | $31.58 |
| Every 3 months | 4 | $45 + $39 + three $59 refills | $261 | $21.75 |
| Every 4 months | 3 | $45 + $39 + two $59 refills | $202 | $16.83 |
Interlude's pricing page says most women choose a two- to four-month refill interval. The product page says the generic cream is usually a two- to three-month supply. Your clinician's directions and actual remaining supply—not the lowest table row—should determine the interval.[1][2]
The actionable insight remains strong without pretending every woman uses the same dose:
The two-month scenario costs $177 more in year one than the four-month scenario. Set the interval deliberately, then use the reminder to postpone a shipment when your prescribed use leaves enough medication.
Do not extend the interval merely to save money if it would interrupt the prescribed regimen.
Is Interlude cheaper than a local pharmacy?
Sometimes. Not automatically.
A local pharmacy may be cheaper when:
- you already have a prescription;
- your plan covers the generic;
- your clinician visit is already paid for;
- a local cash price is below Interlude's recurring price; or
- you need fewer fills than Interlude's initial schedule would send.
Interlude may still be worth more when:
- you cannot obtain a timely prescription;
- your deductible makes the local route expensive;
- you value included messaging and shipment reminders;
- local availability is poor; or
- the time and friction of another appointment are the real problem.
Use your own numbers:
| Your comparison | Amount |
|---|---|
| Local pharmacy price per fill | $___ |
| Local fills needed in 12 months | ___ |
| Visit, copay, or prescriber cost | $___ |
| Local route total | $___ |
| Interlude selected-interval total | $___ |
| Difference | $___ |
The decision is not “Is $39 cheap?” It is “What will this route cost me over the period I will actually use it, and what access problem does the extra cost solve?”
See the complete Interlude cost breakdown →
→ Check Interlude's current price and choose the refill interval Confirm the first checkout total and selected shipment date before payment. (Unpaid link.)
Is Interlude's estradiol FDA-approved, or is it compounded?
Interlude sells both categories in the same shop. Its 0.01% estradiol vaginal cream and 10 mcg estradiol vaginal inserts are presented as FDA-approved generics. Its Soothing Estradiol Cream 0.003%, DHEA Vaginal Cream 2%, and Hyaluronic+ cream are compounded prescriptions. A provider is never “FDA-approved”; that status applies to a specific drug product.[1][9][10][11][12]
The FDA states that compounded drugs are not FDA-approved and that it does not verify the finished compounded product's safety, effectiveness, or quality before marketing. Compounding can meet a legitimate patient need, but a 503A or accreditation claim does not turn a compounded product into an FDA-approved one.[14]
The product categories, side by side
| Interlude product | Published strength | FDA status | Published first / recurring price | What to verify before using it |
|---|---|---|---|---|
| Estradiol vaginal cream | 0.01%; 0.1 mg/g | FDA-approved generic category | $39 / $59 | Manufacturer, NDC, pharmacy, directions |
| Estradiol vaginal inserts | 10 mcg per insert | FDA-approved generic category | $109 / $129 | Manufacturer, NDC, pharmacy, exact dosage form |
| Soothing Estradiol Cream | 0.003%; 0.03 mg/g | Compounded; not FDA-approved | $49 / $69 | Concentration, pharmacy, base, directions, why compounded is preferred |
| DHEA Vaginal Cream | 2%; 5 mg per 0.25 g pump | Compounded; not FDA-approved | $49 / $69 | Pharmacy, route, pump instructions, why compounded cream is preferred |
| Hyaluronic+ Topical Cream | Strengths not itemized on the page | Compounded; not FDA-approved | $39 / $59 | Ingredient amounts, pharmacy, intended internal/external use, interval |
The FDA-approved generic cream checks out at the category level
Interlude publishes a 42.5 g tube of estradiol vaginal cream 0.01%, with 0.1 mg estradiol per gram and an excipient list that matches a current FDA-approved generic label on DailyMed. The current DailyMed label is marketed under an abbreviated new drug application.[1][13]
That supports the claim that Interlude offers an FDA-approved generic product category. It does not identify the manufacturer or NDC that every customer will receive. Check the dispensed label.
The compounded Soothing cream now publishes the number the draft said was missing
Interlude's current page lists:
- estradiol 0.003%, or 0.03 mg/g;
- hyaluronic acid 0.5%;
- aloe 0.5%;
- vitamin E 1%;
- a 30 g dispenser; and
- $49 first-order / $69 recurring pricing.[10]
That is a major improvement in transparency. The earlier criticism that Interlude did not publish the estradiol concentration is no longer true.
The price comparison still matters:
| Price measure | FDA-approved generic cream | Compounded Soothing cream |
|---|---|---|
| Tube size | 42.5 g | 30 g |
| Published concentration | 0.01% | 0.003% |
| First-order price per gram | $0.92 | $1.63 |
| Recurring price per gram | $1.39 | $2.30 |
The compounded cream costs about 77% more per gram on the first order and about 66% more per gram on recurring shipments. That is a price-and-quantity comparison, not a dose-equivalence or efficacy comparison. The concentrations, bases, delivery devices, and prescribed amounts differ.
A different base can be a rational reason for a clinician to choose a compounded formulation when an approved product does not meet a patient's needs. The question to ask is direct:
“Why is this compounded formula a better fit for me than an available FDA-approved vaginal product?”
Interlude's DHEA cream is not Intrarosa
Interlude currently sells a compounded 2% DHEA cream. The page says each 0.25 g pump contains 5 mg DHEA and lists a typical one- to two-pump daily regimen, subject to the prescriber's instructions.[11]
That is not the same finished product as Intrarosa, the FDA-approved 6.5 mg prasterone vaginal insert. Do not collapse the two because both involve prasterone/DHEA. The route, dose, formulation, regulatory review, and labeling differ.
Hyaluronic+ is hormone-free—and still compounded
“Hormone-free” does not mean “FDA-approved.” Interlude's Hyaluronic+ cream is a prescription compounded product with hyaluronic acid, aloe, vitamin E, and a cream base. Its page advertises internal and external use and a 30 g quantity.[12]
The page also uses claims such as healing skin “at the cellular level” and describes one study as finding hyaluronic acid “just as effective” as vaginal estrogen for dryness. Those statements should not be treated as proof that this exact compounded finished product is equivalent to an FDA-approved estrogen drug.
Our own conflict, disclosed
The HRT Index has an affiliate relationship with Inner Balance, which offers a compounded vaginal product. We are not routing readers to it from this FDA-approved-versus-compounded decision section. The product category and reader fit come before payout.
Does the 2026 FDA warning change apply to Interlude's cream or inserts?
No—not as of August 18, 2026. The FDA's current updated-prescribing-information page lists six menopause products: Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva. Estring is the only topical vaginal estrogen on that list. Current DailyMed labels for estradiol vaginal cream 0.01% and 10 mcg estradiol vaginal inserts still carry boxed warnings.[13][15][16]
The FDA began the broader labeling action in November 2025 and approved updated labeling for the first listed products in February 2026. That does not mean every estrogen product changed at once.[15][17]
This is the practical answer:
- Interlude does not sell Estring.
- Its current catalog offers cream and inserts.
- The current cream and insert labels we checked still include boxed-warning language.
- The exact Medication Guide in your package controls for the product you receive.
Do not throw away the label because a headline said “the warning was removed.” Do not assume the label proves local therapy carries the same risk profile as systemic oral estrogen either. The label and the specialty guidance are answering different parts of the decision.
The current 0.01% cream label says systemic absorption may occur and lists undiagnosed abnormal genital bleeding and several other contraindications. The Menopause Society explains that low-dose vaginal estrogen sends very little estrogen into circulation compared with systemic therapy and has a different risk profile.[13][20]
Do you need progesterone with low-dose vaginal estrogen?
The 2020 Menopause Society GSM position statement says a progestogen is not indicated with low-dose vaginal estrogen, while also noting that endometrial safety data beyond one year were limited.[22]
That is not permission to ignore the exact prescription. Estradiol cream dosing can vary, and the current 0.01% cream label says systemic absorption may occur. Follow the prescriber and the label for the product and dose you actually use.[13]
Bleeding after menopause is not a “wait and see whether the cream caused it” problem. It needs prompt evaluation.[21]
Is Interlude a subscription, and how do you cancel it?
Yes. Interlude's terms call it a subscription program and set automatic charges and shipments every two months unless you change the schedule. The FAQ says automatic shipments cannot be switched off while the account remains active. You may postpone a shipment or cancel all shipments; the terms require cancellation at least two business days before the next shipment to avoid the next charge.[3][5]
The controls are straightforward once the distinction is clear:
| What you want to do | Published account path | What happens |
|---|---|---|
| Move one shipment | Shipments → reschedule shipment | The next shipment date moves |
| Receive an earlier refill | Shipments → reschedule refill shipment | The next date moves earlier |
| Stop all future shipments | Payments → “I want to cancel” | The subscription ends |
| Stay enrolled with automatic shipments permanently off | Not offered | The FAQ says this setting does not exist |
Interlude says it emails and texts before shipments so customers can postpone or cancel. Put the next shipment date in your own calendar too. A reminder you control is stronger than a reminder you hope arrives.
What if the clinician declines to prescribe?
Interlude currently gives two answers:
| Live page | What it says | Financial consequence |
|---|---|---|
| Pricing page | If you do not qualify, your payment is refunded | Sounds like the entire payment returns |
| Refund policy | Medication fee is refunded; medical consult fee is not | You lose the $45 consult fee |
Both pages were live on August 18, 2026.[2][8]
Ask before paying. Get the answer in writing. Do not let an affiliate review choose whichever version converts better.
How long does the first prescription last?
Interlude also gives two numbers:
- current checkout copy says the consult is good for seven refills or one year; while
- the FAQ and “transparent pricing” sections say six refills or one year.[1][3]
The practical issue is not whether one number sounds better. It is what happens when the sixth or seventh refill is due and whether a renewal fee appears. Interlude says a renewal requires an updated health profile and may involve a fee, but the amount is not published.[2]
Does Interlude take insurance, HSA, or FSA?
Interlude does not bill insurance. Its FAQ says HSA and FSA cards are accepted and that a receipt can be downloaded from the account. Your plan—not Interlude—decides whether a charge is eligible, whether more documentation is needed, and whether a reimbursement claim will be approved.[3]
A receipt is not automatically a superbill. When reimbursement matters, ask whether the document includes:
- patient name;
- provider name and NPI;
- date of service;
- diagnosis code;
- procedure code;
- separate consult and medication charges; and
- pharmacy information.
Read the full Interlude insurance breakdown →
Can Interlude send the prescription to your local pharmacy?
Yes—outward, not inward.
Interlude's FAQ says it can help transfer an Interlude-issued prescription to a local pharmacy. Its pricing page says it does not accept an existing prescription transferred into Interlude.[2][3]
That creates a legitimate cost-control path:
- Use Interlude for the clinical review if that is the access problem.
- Ask for the exact prescription and transfer rules.
- Price the medication at the local pharmacy.
- Compare that price with Interlude's $59 recurring cream or $129 recurring inserts.
- Ask whether Interlude clinician messaging continues after the transfer.
Do not assume every pharmacy stocks every generic, manufacturer, or dosage form. Call before transferring.
Does vaginal estrogen help recurrent UTIs and urinary urgency?
Local low-dose vaginal estrogen is a guideline-supported option for reducing future recurrent UTIs in peri- and postmenopausal women when appropriate and when there is no contraindication. It is prevention, not treatment for an infection happening now. Evidence for other urinary symptoms is more variable, so urgency, frequency, leakage, and burning still need the correct diagnosis.[19][20]
The 2025 AUA/SUFU/AUGS GSM guideline recommends local low-dose vaginal estrogen for patients with GSM and recurrent UTIs to reduce future UTI risk when appropriate.[19]
That does not mean every urinary symptom is estrogen deficiency. Burning can come from GSM, infection, skin disease, irritation, or another cause. Urgency and leakage can have multiple contributors.
Interlude's active-UTI offer is a separate service
Interlude advertises a $55 same-day online visit and prescription for an active UTI. The antibiotic is sent to a local pharmacy and paid for separately.[4]
Seek prompt evaluation rather than relying on a routine online GSM purchase when there is:
- fever;
- flank or back pain;
- vomiting;
- visible blood in the urine;
- pregnancy or possible pregnancy;
- severe or rapidly worsening symptoms;
- repeated treatment failure; or
- concern for a complicated infection.
The clean distinction is:
- recurrent-UTI prevention: a longer-term GSM and risk-reduction decision;
- active UTI treatment: a current diagnostic and antibiotic decision.
How long can you use vaginal estrogen?
GSM is chronic and often requires long-term management. Current reviews do not establish an evidence-based mandatory stopping age or fixed maximum duration for low-dose vaginal estrogen; treatment is periodically reassessed for benefit, side effects, bleeding, product fit, and changes in health history. Symptoms commonly return when effective treatment stops.[18][23]
The draft's emotional truth survives the accuracy edit: this is not usually a one-tube cure.
What changes is the wording. “Use it indefinitely” is too blunt because:
- the exact product and dose matter;
- the current cream label carries contraindications and precautions;
- a woman's health history can change;
- unexplained bleeding requires evaluation; and
- a treatment that is not helping should be reassessed.
Interlude's current generic cream and insert pages say there is no age limit and that treatment may continue as long as needed to prevent symptoms from returning.[1][9]
That is a genuine access advantage for older women—but it is a provider policy, not a promise that every applicant at every age will qualify.
What do Interlude reviews actually say?
Interlude's Trustpilot profile showed a 4.8 rating and 956 reviews when checked on August 18, 2026. The most consistent positive themes are easy ordering, fast clinician response, delivery, and the ability to delay automatic shipments. Those reviews describe the service experience; they do not prove that a drug is safe, effective, or appropriate for a particular reader.[24]
Interlude's own reviews page says it does not offer incentives for positive reviews and only links to reviews shared publicly. The same page labels the reviews it displays as its “favorite” reviews, which means the homepage selection is a highlight reel rather than a balanced sample.[25]
Three attributable service-experience excerpts
“They give you the choice to delay delivery.” — Tricia Olson, verified Trustpilot review, June 27, 2026[24]
“The process of ordering ... very easy.” — D. France, verified Trustpilot review, July 9, 2026[24]
“Within an hour I had a response.” — “Happy customer,” verified Trustpilot review, January 12, 2026[24]
These excerpts support three narrow claims: shipment flexibility, ordering ease, and a reported response time. They do not support medical outcome claims.
The counterweight matters. A verified three-star review dated June 23, 2026 said the directions felt too broad and that the initial supply ran out sooner than expected. That is one person's experience, not proof of a systemwide problem—but it reinforces the best practical instruction on this page: read the prescribed gram amount, ask how long the dispensed quantity should last, and set the refill interval from that answer.[24]
We do not publish testimonials claiming that Interlude “cured” a symptom, prevented a disease, or worked for everyone. A customer can establish that a package arrived. A customer cannot establish what is safe for your medical history.
Where does Interlude's medical copy run hotter than the evidence?
Interlude's product pages are unusually detailed for direct-to-consumer telehealth, but several statements are broader than an independent YMYL page should repeat. The problems are not that local vaginal therapy lacks evidence; the problems are absolute safety language, marketing claims attached to compounded products, and product-specific conclusions that outrun the cited source.
| Current Interlude statement or presentation | Production-safe interpretation |
|---|---|
| “There is no evidence” of cancer, cardiovascular disease, stroke, dementia, or any other serious problem | Observational data are reassuring for low-dose vaginal estrogen, but “no evidence of any serious problem” is broader than current labels and individualized risk guidance support |
| FDA-approved generic pages say the product is safe even for women who cannot take other menopause hormone therapy | Local therapy has much lower systemic exposure, but the current label still contains contraindications and says systemic absorption may occur |
| The compounded Soothing page calls estradiol “clinically proven” | Evidence about estradiol does not make the finished compounded formulation FDA-reviewed or clinically equivalent to an approved product |
| Hyaluronic+ says it heals skin “at the cellular level” and cites one study as “just as effective” for dryness | That does not establish equivalence of this exact compounded product to an FDA-approved estrogen therapy across GSM outcomes |
| Product pages use broad prevention language for incontinence and UTIs | Recurrent-UTI prevention has guideline support; urinary urgency, leakage, and infection symptoms still require diagnosis and individualized treatment |
The reader-safe rule is simple:
- trust the product page for the published price, quantity, ingredient list, and stated workflow;
- use the FDA label and specialty guidance for regulatory and medical claims; and
- use the assigned clinician for the decision about your history and prescription.
Where do Interlude's own pages disagree?
Eight current conflicts remain across Interlude's homepage, product pages, FAQ, pricing page, refund policy, terms, telehealth consent, and contact page. Most look like version-control problems rather than evidence of bad faith. Each can still change what you pay, what you receive, or what you expect from the service.
| # | One Interlude page says | Another Interlude page says | Why it matters |
|---|---|---|---|
| 1 | Consult covers 7 refills or one year | FAQ and pricing blocks say 6 refills or one year | Renewal timing and one additional authorization differ |
| 2 | If you do not qualify, your payment is refunded | Refund policy says medication is refunded but the consult is not | $45 difference |
| 3 | Homepage says inserts start at $89 | Current insert product page charges $109 first / $129 recurring | $20 first-order difference and $40 from the displayed starting figure to recurring price |
| 4 | Terms limit consultations to GSM and related conditions | Current shop sells acute UTI, BV, and yeast visits | The legal scope page has not caught up with the catalog |
| 5 | Insert page calls 18 inserts a 2-month supply | The same page describes 14 daily starter doses followed by twice-weekly use | About 4 weeks for a new starter versus about 9 weeks at maintenance; the prescription must set refill timing |
| 6 | Contact page lists phone hours 10 a.m.–4 p.m. Pacific | Product FAQ lists 9 a.m.–5 p.m. Pacific | When live phone support is actually available |
| 7 | Interlude terms identify GML Health, Inc. | Telehealth consent uses GML Health with M&D Integrations and then contracts through M&D language | Who operates the platform and which terms govern the telehealth layer |
| 8 | Marketing says online care is available in all 50 states | Telehealth consent says services are available only in certain states and points to a list that did not surface | State eligibility must be confirmed before payment |
Source: Sources checked August 18, 2026.[1][2][3][4][5][6][7][8][9]
Get load-bearing details in writing. The current checkout, assigned clinician, pharmacy label, and dated support response are more useful than an old FAQ.
Who should not use Interlude as the first stop?
Interlude is the wrong first stop when the symptoms may require an examination, urgent testing, or a broader systemic-menopause assessment. Its own telehealth consent says remote clinicians may lack information obtained through a hands-on examination. A fast prescription route is a feature only when the condition is appropriate for remote care.[6]
Arrange prompt in-person or local clinical evaluation for
- bleeding after menopause;
- a new lump, ulcer, sore, color change, or visible vulvar lesion;
- significant pelvic pain;
- fever, flank pain, vomiting, or visible blood in the urine;
- repeated presumed infections without testing or durable improvement;
- symptoms that continue despite an appropriate treatment trial;
- pregnancy or possible pregnancy;
- a history that makes the current product label contraindications relevant; or
- any emergency.
A history of breast or another estrogen-sensitive cancer is not a one-line internet prohibition. Current guidance generally starts with nonhormonal options for people with estrogen-dependent breast cancer, then allows individualized shared decision-making about low-dose vaginal treatment when symptoms persist, often in coordination with oncology.[26]
That decision deserves the clinicians who know the cancer type, treatment, recurrence risk, and current medicines. It should not be reduced to “get oncologist approval” in a checkout tooltip.
Choose a different care route when
- Hot flashes or night sweats are the main problem: use a systemic-menopause provider.
- You want insurance billed: compare an insurance-taking menopause clinic or your current clinician.
- You already have a prescription: price the fill before buying another consult.
- You want a ring: choose a clinician who can prescribe to a pharmacy and discuss the exact local or systemic ring.
- You want an examination before treatment: book local gynecology, primary care, urology, or a cash-pay in-person visit.
→ Compare local and virtual visit prices on Sesame Care Choose this route when selecting the clinician or having an in-person option matters more than a bundled shipment. (Affiliate link.)
How does Interlude compare with the other ways to get vaginal estrogen?
Interlude competes most directly with a local prescriber plus pharmacy and with other focused vaginal-health telehealth services—not with every full-service menopause clinic. It wins when prescription access and convenience are the bottleneck. It loses when you already have low-cost pharmacy access, need insurance, need a physical examination, or need systemic HRT.
| Route | Best fit | Insurance model | Scope | Main tradeoff |
|---|---|---|---|---|
| Interlude | Focused vaginal/urinary care, cash-pay access, delivery | No insurance billing | Narrow | Automatic shipment, product-page conflicts, recurring price can exceed a local fill |
| Your clinician + local pharmacy | Existing relationship, examination, coverage, specific manufacturer | Often available | Depends on clinician | Appointment and prescription-access friction |
| Midi Health | Broader menopause symptoms and longitudinal virtual care | In-network with many PPOs; plan-dependent | Broad | No shipped medication bundle; federal/state program rules differ |
| Sesame Care | One chosen visit, visible appointment price, virtual or local options | Cash-pay | Broad marketplace | Medication and follow-up are separate |
| Another focused vaginal-health service | Similar remote access | Varies | Narrow to moderate | Must re-check formulary, product status, price, and cancellation terms |
See eight alternatives to Interlude →
Why Hers is not a route on this page
The HRT Index has an affiliate relationship with Hers. We are not routing readers there from a page centered on subscription enrollment, billing, privacy, and cancellation.
On July 29, 2026, the FTC, joined by Utah and California through Los Angeles County, filed a pending federal complaint against Hims & Hers Health alleging deceptive billing, difficult cancellation, and unlawful health-data practices. The allegations have not been adjudicated, and the company can contest them.[29]
That action does not prove every Hers service is unsafe or deceptive. It makes Hers a poor editorial recommendation in this specific subscription-friction decision until the case and current practices are reassessed.
What should you ask Interlude before you pay?
These eight questions convert the live conflicts into answers you can save. The checklist requires no email address, account, or purchase: copy it into a note, send it through support, and keep the dated reply with your receipt.
- [ ] If the clinician does not prescribe, are both the medication charge and the $45 consult refunded?
- [ ] Is my exact state and location eligible for this treatment today?
- [ ] Does this consult authorize six refills or seven, and what happens when the authorization expires?
- [ ] What renewal fee applies after the first year?
- [ ] Which exact product, strength, quantity, manufacturer, and pharmacy will I receive?
- [ ] Is the product FDA-approved or compounded?
- [ ] If I transfer the prescription to a local pharmacy, does clinician messaging continue?
- [ ] What shipment interval is selected, and how long should this quantity last at my prescribed dose?
The micro-commitment is simple: do not click away and promise yourself you will remember. Answer the eight questions before the charge.
Should you choose Interlude? Our verdict under The HRT Index Verification Standard
Interlude is a legitimate, focused route to vaginal and urinary prescription care—and a poor substitute for comprehensive menopause treatment. Its strongest product is the transparent FDA-approved generic cream path. Its biggest commercial weaknesses are automatic shipment, pay-before-review, unresolved refund language, six-versus-seven refill language, and a site that still displays conflicting state and price information.
We evaluate providers under The HRT Index Verification Standard using the same five pillars in the same order. We do not invent numeric scores.
| Pillar | What holds up | What does not |
|---|---|---|
| Clinical legitimacy | Published telehealth consent, clinician review, prescription requirement, named fulfillment partners | GML/M&D documents are confusing; individual clinician and pharmacy credentials still need patient-level confirmation |
| Care quality | Focused intake, secure messaging, fast published review window, refill reminders | No physical exam or routine lab pathway is published; payment comes before assessment; remote diagnosis has acknowledged limits |
| Medication fit | FDA-approved generic cream and inserts; compounded products now disclose more formula detail | FDA-approved and compounded products sit together; Interlude does not sell systemic HRT or a vaginal ring |
| Price transparency | $45 consult and major product prices are now published; first and recurring prices are shown on product pages | $89 versus $109 insert price conflict; six versus seven refills; renewal fee unpublished; refund pages conflict |
| Access | Online workflow, free standard shipping, messaging, HSA/FSA claims, transfer-out option | No insurance billing; state claims conflict; automatic shipments cannot be disabled while staying enrolled |
Choose Interlude if all four are true
- Your main symptoms are vaginal or urinary.
- You know whether the product is FDA-approved or compounded and why that category fits.
- You have compared the full first-year cost with your local route.
- You have set the shipment interval and saved the cancellation date.
Skip it or compare first when any of these are true
- You need systemic menopause care.
- You need insurance billed.
- You have bleeding after menopause or symptoms that require an examination.
- You already have a prescription.
- The exact product or pharmacy has not been confirmed.
- Automatic shipments are a dealbreaker.
- Support will not resolve the refund contradiction in writing.
→ Check Interlude's current products, pricing, and eligibility Confirm the refund answer, selected interval, product category, and state before payment. (Unpaid link — The HRT Index earns nothing from Interlude.)
How did we verify this Interlude menopause review?
This is independent editorial research, not a clinical review, paid test, or sponsored placement. We checked Interlude's live commercial and policy pages on August 18, 2026; classified its current product catalog; recalculated first-year costs from published prices; compared FDA-approved and compounded categories; reviewed current FDA labels and specialty guidance; and documented unresolved conflicts rather than guessing.
What we actually reviewed
- Interlude homepage and shop
- Generic estradiol cream product page
- Generic 10 mcg insert product page
- Soothing Estradiol Cream product page
- DHEA Vaginal Cream product page
- Hyaluronic+ Topical Cream product page
- Pricing page
- FAQ
- How-it-works flow
- Terms of service
- Telehealth consent
- Refund policy
- Contact and pharmacy-partner page
- Interlude reviews policy
- Current Trustpilot profile
- FDA compounded-drug guidance
- FDA's current list of menopause products with updated prescribing information
- Current DailyMed labels for estradiol vaginal cream and inserts
- The Menopause Society's current patient guidance and 2020 GSM position statement
- The 2025 AUA/SUFU/AUGS GSM guideline
- Current peer-reviewed review literature on GSM duration
- Current ACOG/PubMed guidance relevant to postmenopausal bleeding and breast-cancer history
What remains unverified at the individual-customer level
- the exact clinician assigned to a reader;
- that clinician's active state license at the moment of care;
- the dispensing pharmacy for a specific order;
- the manufacturer and NDC of a shipped generic;
- the exact checkout tax or expedited-shipping charge;
- whether a state gate will approve a particular reader and product;
- the amount of the renewal fee after the first year;
- which refund promise Interlude will honor when no prescription is issued;
- whether messaging survives a prescription transfer; and
- whether the current pharmacy accreditation statements remain active with the relevant accreditor.
These are not blanks to fill with confident prose. They are the questions the reader should confirm.
Update log
| Date | What changed |
|---|---|
| August 18, 2026 | First publication audit. Reverified prices, catalog, consult fee, product strengths, automatic-shipment terms, refund conflict, pharmacy disclosures, current FDA labeling list, Trustpilot rating/count, and state-availability conflict. |
Found a price, product, policy, or label that changed? Send the dated source through The HRT Index corrections channel. Material corrections belong in the update log.
Interlude menopause review: frequently asked questions
These direct answers close the pricing, prescription, insurance, cancellation, FDA-status, state, and safety follow-ups most likely to matter before a decision. Where Interlude publishes conflicting rules, the answer names the conflict instead of choosing the more convenient version.
Is Interlude legit?
Yes. Interlude publishes an identifiable operating entity, telehealth documents, clinician-review workflow, phone and mailing details, four pharmacy partners, product pages, account controls, and prescription requirements. The risks worth investigating are not whether the storefront exists; they are the product category, pay-before-review workflow, automatic shipments, refund conflict, state eligibility, and total cost.
How much does Interlude cost?
The current FDA-approved generic estradiol cream costs $39 for the first tube and $59 for later tubes, plus a $45 one-time consult. That makes the first checkout about $84 before tax or optional expedited shipping. At six shipments in twelve months, the illustrative first-year total is $379. Verify the selected interval before paying.
Is the $39 Interlude price permanent?
No. It is the first-shipment promotional price for selected products. The current recurring generic-cream price is $59. Interlude advertises a $20 first-shipment discount, so the promotional and ongoing prices must be shown separately.
What do the estradiol inserts cost?
The current insert product page shows $109 for the first box and $129 for later boxes, plus the $45 routine consult. The homepage still says “starting at $89.” The box contains 18 inserts: about four weeks under the page’s published starter schedule or about nine weeks at twice-weekly maintenance, so confirm both the price and prescribed refill timing.
Does Interlude take insurance?
No. Interlude says it does not accept insurance. It says HSA and FSA cards are accepted and that receipts can be downloaded, but account rules control eligibility and reimbursement. A local pharmacy fill may cost less when insurance covers the generic.
Is Interlude's estradiol cream FDA-approved?
Interlude's 0.01% estradiol vaginal cream is sold as an FDA-approved generic category. The published strength, quantity, and excipient list align with a current FDA-approved generic label. Confirm the exact manufacturer and NDC on the pharmacy label because fulfillment can vary.
Are all Interlude products FDA-approved?
No. The generic estradiol cream and 10 mcg inserts are the FDA-approved options in the current catalog. Soothing Estradiol Cream, DHEA Vaginal Cream, and Hyaluronic+ Topical Cream are compounded products and are not FDA-approved.
What is the concentration of Interlude's Soothing Estradiol Cream?
Interlude now publishes estradiol 0.003%, equal to 0.03 mg/g, in a 30 g dispenser. The draft criticism that its concentration was missing is outdated. It remains a compounded product, not an FDA-approved generic.
Is Interlude's DHEA cream the same as Intrarosa?
No. Interlude sells a compounded 2% DHEA cream, with 5 mg in each 0.25 g pump. Intrarosa is an FDA-approved 6.5 mg prasterone vaginal insert. They differ in formulation, dose, route, regulatory review, and labeling.
Does Interlude treat hot flashes?
No. Its current catalog is focused on vaginal and urinary care and does not include systemic estrogen patches, gels, sprays, or pills. For hot flashes, night sweats, and broader menopause symptoms, compare a comprehensive menopause provider.
Does Interlude require a video visit?
Not routinely. Interlude says clinician follow-up may happen by secure message, phone, or video. The exact requirement can depend on the clinician, state, and medical situation. A prescription is not guaranteed merely because payment and intake were completed.
Does Interlude include labs?
Interlude's published routine GSM workflow does not list laboratory testing. Its telehealth consent emphasizes remote review and acknowledges that the clinician may not have information obtained through a physical examination. A local clinician may be a better starting point when testing or examination is needed.
Is Interlude available in all 50 states?
Interlude marketing says all 50 states. Its telehealth consent says certain services are available only in certain states and references a state list that did not surface during this audit. Confirm the exact product and your physical location before paying.
How do I cancel Interlude?
Log in, open the Payments area, and select “I want to cancel.” Interlude's terms say to cancel at least two business days before the next shipment to avoid the next charge. To move one shipment rather than cancel everything, use the Shipments area and reschedule it.
Can I turn off automatic shipments without cancelling?
No, according to Interlude's FAQ. You can postpone an individual shipment or cancel all shipments. The FAQ says there is no setting that leaves the account active while permanently switching off automatic shipments.
What happens if the clinician will not prescribe?
Interlude's current pages conflict. The pricing page says your payment is refunded if you do not qualify; the refund policy says only the medication fee is refunded and the consult fee is not. Ask whether the $45 consult returns and keep the written answer.
How long does the prescription last?
Interlude publishes both six and seven refills, with a one-year maximum. It also says a renewal health profile and fee may apply after expiration, but the renewal amount is not published. Confirm the authorized refill count on your prescription or account.
Can I transfer an Interlude prescription to a local pharmacy?
Interlude's FAQ says yes and directs customers to email support for help. Its pricing page says Interlude does not accept an existing prescription transferred into the service. Ask whether clinician messaging and other account benefits continue after an outward transfer.
Does vaginal estrogen help prevent recurrent UTIs?
Current AUA/SUFU/AUGS guidance supports local low-dose vaginal estrogen to reduce future recurrent UTI risk in appropriate peri- and postmenopausal patients without a contraindication. It does not treat an infection that is active now.
Do I need progesterone with vaginal estrogen?
The Menopause Society's 2020 GSM position statement says a progestogen is not indicated with low-dose vaginal estrogen. The exact product and prescribed dose still matter, and current cream labeling notes that systemic absorption may occur. Follow the clinician and the label rather than adding a hormone on your own.
Can I use vaginal estrogen after breast cancer?
That decision is individualized. Current guidance generally starts with nonhormonal options for people with estrogen-dependent breast cancer and allows shared decision-making about low-dose vaginal treatment when symptoms persist, often with oncology involvement. An online intake should not replace that cancer-specific discussion.
How long can I keep using vaginal estrogen?
GSM is chronic, and current reviews do not establish a mandatory stopping age or fixed evidence-based duration limit for low-dose vaginal estrogen. Continued use should be periodically reassessed for benefit, bleeding, side effects, product fit, and changes in medical history.
Does Interlude sell a vaginal ring?
No. Interlude currently sells vaginal creams and 10 mcg inserts. Estring is the only topical vaginal estrogen on the FDA's current list of menopause products with updated 2026 prescribing information, and Interlude does not offer it.
Is Interlude cheaper than my local pharmacy?
It can be, especially when the problem is obtaining a prescriber or paying through a high deductible. It can also cost more than a local generic fill after the promotional shipment. Compare twelve-month totals using your own pharmacy price, visit cost, fill count, and Interlude interval.
What is the difference between the cream and the inserts?
The cream comes in a 42.5 g tube with a reusable applicator and allows a clinician to prescribe a gram amount. The inserts contain a fixed 10 mcg dose in prefilled applicators and are less messy for some users. Both current generic categories are FDA-approved; the prices and dosing instructions differ.
Still not sure which HRT program is right for you? Take our free 90-second matching quiz.
You've read the scope, prices, formulas, contracts, and contradictions. The last question is whether a focused vaginal-health service is the right starting point for your symptoms—or whether you need broader or in-person care.
→ Find My HRT Path Your symptoms, state, coverage, route preference, and safety flags. Free, no account, and it will tell you when the correct answer is “see someone in person.”
Educational research only. Not medical advice, a diagnosis, or a substitute for a clinician who knows your history. Do not start, stop, transfer, or change prescription treatment without the prescribing clinician's guidance.
Sources
1 Interlude, Estradiol vaginal cream product page, checked August 18, 2026.
2 Interlude, Pricing, checked August 18, 2026.
3 Interlude, Frequently Asked Questions, last-updated stamp February 10, 2025; checked August 18, 2026.
4 Interlude, Current shop and acute-care prices, checked August 18, 2026.
5 Interlude, Terms of Service, last-updated stamp March 1, 2023; checked August 18, 2026.
6 Interlude, Consent to Telehealth, checked August 18, 2026.
7 Interlude, Contact and pharmacy-partner disclosures, checked August 18, 2026.
8 Interlude, Refunds and Returns, last-updated stamp February 12, 2025; checked August 18, 2026.
9 Interlude, Estradiol vaginal inserts product page, checked August 18, 2026.
10 Interlude, Soothing Estradiol Cream product page, checked August 18, 2026.
11 Interlude, DHEA Vaginal Cream product page, checked August 18, 2026.
12 Interlude, Hyaluronic+ Topical Cream product page, checked August 18, 2026.
13 DailyMed, Estradiol Vaginal Cream 0.01% label, updated August 11, 2026.
14 U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers, updated September 16, 2025; and What to Know When Promoting Compounded Drugs, updated June 15, 2026.
15 U.S. Food and Drug Administration, Menopausal Hormone Therapies with Updated Prescribing Information, checked August 18, 2026.
16 DailyMed, Estradiol Vaginal Inserts 10 mcg label, checked August 18, 2026.
17 U.S. Food and Drug Administration, HHS Advances Women’s Health, Removes Misleading FDA Warnings from Hormone Replacement Therapy, November 10, 2025.
18 The Menopause Society, MenoNotes: Genitourinary Syndrome of Menopause, checked August 18, 2026.
19 American Urological Association, Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline, 2025.
20 The Menopause Society, Hormone Therapy, checked August 18, 2026.
21 American College of Obstetricians and Gynecologists, Updated Guidance Regarding the Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding, 2026.
22 The NAMS 2020 GSM Position Statement Editorial Panel, The 2020 Genitourinary Syndrome of Menopause Position Statement, Menopause. 2020;27(9):976–992.
23 Cyriac J, et al., Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause, 2026.
24 Trustpilot, Interlude customer reviews, live rating and count checked August 18, 2026.
25 Interlude, Reviews policy, checked August 18, 2026.
26 The Menopause Society and the International Society for the Study of Women’s Sexual Health, Management of Genitourinary Syndrome of Menopause in Women With or at High Risk for Breast Cancer, 2018; and Cyriac J, et al., Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause, 2026.
27 Midi Health, Menopause care, HRT and insurance information, and How Midi Works, checked August 18, 2026.
28 Sesame Care, Current visit marketplace, checked August 18, 2026.
29 Federal Trade Commission, FTC and States Act Against Hims & Hers for Deceptive and Unlawful Privacy Practices, July 29, 2026; case status pending when checked August 18, 2026.
